Nifuroxazide-induced acute pancreatitis: a new side-effect for an old drug?
We report the case of a middle-aged woman who developed a typical picture of acute pancreatitis together with systemic features of immunoallergy after the intake of two capsules (200 mg) of nifuroxazide. Even if acute pancreatitis is a rare adverse event of nitrofuran derivative therapy, nifuroxazide-induced pancreatitis as not been previously described. As suggested by associated systemic features, the disease is likely of immunoallergic origin.
Shindano
Akilimali
A
Dept. of Gastroenterology and Dermatology, St. Luc University Hospital, Université Catholique de Louvain, Brussels, Belgium.
Marot
Liliane
L
Geubel
André P
AP
D000208:Acute Disease; D000890:Anti-Infective Agents / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology; D005260:Female; D006801:Humans; D062385:Hydroxybenzoates / Q000009:adverse effects*; D008875:Middle Aged; D009581:Nitrofurans / Q000009:adverse effects*; D010195:Pancreatitis / Q000139:chemically induced*
D000890:Anti-Infective Agents; D062385:Hydroxybenzoates; D009581:Nitrofurans; C013150:nifuroxazide